Cavanaugh Michael R. 4
4 · Vitality Biopharma, Inc. · Filed Jul 1, 2019
Insider Transaction Report
Form 4
Cavanaugh Michael R.
DirectorChief Executive Officer
Transactions
- Award
Stock Option(Right to Buy)
2019-06-27+250,000→ 750,000 totalExercise: $0.30Exp: 2029-06-27→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]Subject to the Reporting Person's continuous service to the Corporation, 1/2 of the shares subject to the option vest upon the earlier of 12 months after the date of grant or shareholder approval of an increase in shares of common stock available for issuance under the Corporation's 2012 Stock Incentive Plan and 1/2 of the shares will vest 12 months after that date. In the event of the Reporting Person's departure from the Corporation for any reason other than for cause, all shares subject to the Option Grant will vest 100%.